About this item
SEREBETO is uniquely blended pre-probiotic composition for management of Diabetes. (Scientifically designed probiotic blend by CSIR)
- Lactobacillus acidophilus, Bifidobacterium bifidum and Streptococcus thermophilus may help in improving glycemic control and reduce fasting plasma glucose levels.
- Lacticaseibacillus casei enhance the glycemic response.
- Probiotic Lactobacillus acidophilus, Lacticaseibacillus casei, Bifidobacterium breve and Prebiotic Fructo-oligosaccharides synergistically portray reduction in average blood glucose levels and weight of an individual.
- Probiotics improve glucose homeostasis by changing the composition of the host gut microbiota.
- Altering the gut microbiota can improve intestinal barrier integrity to reduce circulating bacterial endotoxin, and ultimately, reduce systemic inflammation.
- The gut microbiota may also modulate production of enteroendocrine peptides in the gut, which results in a reduction of gastric emptying time and food intake, and an increase in insulin secretion.
- Probiotics may alter microbiota-derived metabolites, such as butyrate and acetate, which have been associated with changes in glucose metabolism and lipid metabolism and appetite signalling.
No Reviews Found